$Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis$

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated both efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients infected with hepatitis B virus (HBV). However, its applicability in individuals with liver cirrhosis remains largely unexplored due to the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Danqing Kong, Nana Ping, Qian Zhu, Xiao Zhang, Junhong Li, Rui Zou, Depei Wu, Zhengming Jin, Changju Qu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Oncology
Subjects:	diffuse large B-cell lymphoma cirrhosis chimeric antigen receptor T-cell therapy hepatitis B virus case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1491100/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Bacterial infection adversely increases the risk of decompensation in patients with hepatitis B virus-related compensated cirrhosis: a retrospective study
by: Yinglun Li, et al.
Published: (2024-12-01)

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
by: Tingting Yang, et al.
Published: (2025-01-01)

Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma
by: Jianmin Guo, et al.
Published: (2024-11-01)

Fibrinogen dysfunction and fibrinolysis state in patients with hepatitis B-related cirrhosis
by: Yu Liu, et al.
Published: (2024-12-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Editorial: Community series in BCR signaling and B cell activation, volume 2
by: Wenxia Song, et al.
Published: (2025-01-01)

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
by: Lu Cao, et al.
Published: (2025-01-01)

Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination
by: Angela Domínguez, et al.
Published: (2024-11-01)

Predictive factors for clinical cure in the treatment of HBeAg(−) chronic hepatitis B or compensated cirrhosis: a prospective observational study
by: Yan-Qing Lv, et al.
Published: (2025-01-01)

Cytokine release syndrome after chimeric antigen receptor T cell therapy in patients with diffuse large B-cell lymphoma: a systematic review
by: Andressa Rodrigues dos Santos, et al.
Published: (2024-12-01)

Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies
by: Fei Yu, et al.
Published: (2024-12-01)

Identification of multiple complications as independent risk factors associated with 1-, 3-, and 5-year mortality in hepatitis B-associated cirrhosis patients
by: Duo Shen, et al.
Published: (2025-02-01)

The role of B cells in the pathogenesis of type 1 diabetes
by: Ya-nan Wang, et al.
Published: (2024-12-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma
by: Daniel H. Chen, et al.
Published: (2024-12-01)

Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021
by: Quanwei He, et al.
Published: (2025-01-01)

MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivo
by: Thomas V. Guy, et al.
Published: (2024-12-01)

Cutting-edge assessment techniques for B cell immune memory: an overview
by: Martina Bozhkova, et al.
Published: (2024-12-01)

Fanconi Syndrome Due to Tenofovir Disoproxil Fumarate in a Patient with Chronic Hepatitis B Induced Cirrhosis: A Case Report
by: Milad Khodabakhshi, et al.
Published: (2024-11-01)

Immunological process of T cells and IgM+ B cells in head kidney and peripheral blood in early vertebrate Nile tilapia
by: Yuying Zheng, et al.
Published: (2025-06-01)

Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study
by: Zehong Wang, et al.
Published: (2024-12-01)

Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma
by: Pengxiang Gao, et al.
Published: (2024-12-01)

Role of Bruton's Tyrosine Kinase in B Cell Development
by: Alex Maas, et al.
Published: (2001-01-01)

Lymphoblastoid cell lines do not recapitulate physiological circulating B cell subtypes
by: Connie MacKinnon, et al.
Published: (2024-01-01)

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01)

Chimeric antigen receptor T-cell therapy in autoimmune diseases
by: Jie Liu, et al.
Published: (2024-11-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
by: He Qian, et al.
Published: (2024-12-01)

Changes in and Potential Mechanisms of Circulating IgA+CD27-Class-Switched Memory B Cells in Patients With Allergic Rhinitis
by: Zheng H, et al.
Published: (2025-01-01)

Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure
by: Shuqin Gu, et al.
Published: (2024-12-01)

Distinct distribution and responses of IgM+, IgT1+ and IgT2+ B cells in common carp
by: Awatif Eltijani, et al.
Published: (2024-11-01)

Increased IgD and CD27 Double Negative (DN) B cell population in pediatric onset autoimmune hepatitis
by: Vasantha L. Kolachala, et al.
Published: (2024-12-01)

Mesenchymal Stem Cells and Their Derived Exosomes Mitigated Hepatic Cirrhosis in Rats by Altering the Expression of miR-23b and miR-221
by: Somia H. Abd-Allah, et al.
Published: (2024-11-01)

Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
by: S. N. Batskikh
Published: (2021-04-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Essential roles of B cell subsets in the progression of MASLD and HCC
by: Nataliia Petriv, et al.
Published: (2024-12-01)

Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
by: Jin Yin, et al.
Published: (2024-12-01)

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
by: Valentina Giudice, et al.
Published: (2022-04-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)